Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,376,925
Closed -$21.4M 3806
2025
Q3
$18.4M Buy
1,376,925
+1,107,665
+411% +$13.1M 0.07% 205
2025
Q2
$3.45M Sell
269,260
-43,291
-14% -$519K 0.02% 691
2025
Q1
$3.22M Sell
312,551
-278,835
-47% -$3.59M 0.02% 612
2024
Q4
$7.52M Buy
+591,386
New +$7.82M 0.04% 291
2023
Q4
Sell
-13,671
Closed -$233K 2885
2023
Q3
$233K Buy
+13,671
New +$228K ﹤0.01% 1772
2023
Q2
Sell
-539,603
Closed -$9.47M 3050
2023
Q1
$9.47M Buy
539,603
+227,623
+73% +$3.44M 0.12% 147
2022
Q4
$3.96M Sell
311,980
-319,127
-51% -$3.94M 0.06% 328
2022
Q3
$7.96M Buy
+631,107
New +$11.1M 0.09% 174
2022
Q2
Sell
-534,961
Closed -$11.5M 3524
2022
Q1
$11.5M Buy
534,961
+201,672
+61% +$6.8M 0.08% 131
2021
Q4
$14.4M Buy
+333,289
New +$16.4M 0.08% 117
2021
Q3
Sell
-257,811
Closed -$17.5M 3636
2021
Q2
$17.5M Buy
+257,811
New +$18.9M 0.16% 103

Other funds holding PATH

HRT Financial's PATH Position: Q4 2025 in Review

HRT Financial sold out of UiPath (PATH) in Q4 2025, closing a stake of 1,376,925 shares — an estimated $21.4M sold.

HRT Financial first reported a position in PATH in Q2 2021 and held it in 11 quarters. The position peaked at $18.4M in Q3 2025. 539 funds tracked by Wall St. Rank hold PATH as of Q4 2025.

  • HRT Financial reported no remaining UiPath position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 1,376,925 UiPath shares in Q4 2025, an estimated $21.4M.
  • HRT Financial first reported a position in UiPath in Q2 2021 and held it in 11 quarters.
  • HRT Financial's UiPath position peaked at $18.4M in Q3 2025.
  • 539 funds tracked by Wall St. Rank held UiPath as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.